Geographic spillover of antimicrobial resistance from mass distribution of azithromycin
Ariktha Srivathsan1,2, Ahmed M Arzika3, Ramatou Maliki3
1Francis I Proctor Foundation, University of California San Francisco, San Francisco, USA.
Abstract:
Large-scale, placebo-controlled, cluster-randomized trials in high-mortality settings in sub-Saharan Africa demonstrated a 14-18% reduction in childhood mortality following twice-annual mass drug administration (MDA) of azithromycin among children aged 1-59 months. Azithromycin MDA also selected for antimicrobial resistance (AMR), particularly macrolide resistance. It is unknown whether the AMR from azithromycin MDA could spill over to neighboring untreated populations. If present, such geographic spillover effects could lead trials to underestimate AMR risks. We assess between-village geographic spillover effects of genotypic macrolide resistance using metagenomic deep sequencing in rectal swabs collected from 300 children in 30 monitoring villages in Niger after two years of MDA in 594 surrounding villages. Conditional permutation tests assess associations between proximal azithromycin treatment intensity and resistance gene abundance. We find no evidence of geographic spillover of macrolide resistance in untreated villages, as the genetic load of AMR remains at baseline levels in placebo-treated villages regardless of surrounding azithromycin treatment intensity (Spearman ρ = -0.05, P = 0.83). Sensitivity analyses confirm robustness across metrics, and no spillover effects are detected for other antibiotic classes. Azithromycin MDA-induced macrolide resistance appears localized to treated villages, mitigating some concerns about geographic spillover of AMR to nearby untreated villages at 24 months.
Insights
Mass drug administration of azithromycin reduces childhood mortality but can increase antimicrobial resistance (AMR). This study found no evidence of azithromycin-induced macrolide resistance spreading to untreated villages in Niger.
Area of Science:
- Global Health
- Infectious Diseases
- Microbiology
Background:
- Mass drug administration (MDA) with azithromycin significantly reduces childhood mortality in sub-Saharan Africa.
- MDA with azithromycin is associated with increased antimicrobial resistance (AMR), particularly macrolide resistance.
- Potential geographic spillover of AMR to untreated populations could impact trial risk assessments.
Purpose of the Study:
- To investigate geographic spillover effects of genotypic macrolide resistance following azithromycin MDA.
- To assess if AMR developed in treated areas spreads to neighboring untreated communities.
Main Methods:
- Metagenomic deep sequencing of rectal swabs from children in Niger.
- Analysis of 300 children in 30 monitoring villages after two years of MDA in surrounding villages.
- Conditional permutation tests to assess associations between azithromycin treatment intensity and resistance gene abundance.
Main Results:
- No evidence of geographic spillover of macrolide resistance was detected in untreated villages.
- The genetic load of AMR remained at baseline levels in placebo-treated villages, irrespective of surrounding azithromycin treatment intensity.
- Sensitivity analyses confirmed no spillover effects for other antibiotic classes.
Conclusions:
- Azithromycin MDA-induced macrolide resistance appears localized to treated villages.
- Concerns regarding the geographic spillover of AMR to nearby untreated villages were mitigated at 24 months.
- Findings suggest that localized AMR effects do not significantly impact untreated populations in the study setting.
More Related Videos
04:26Author Spotlight: Advancing Mycobacterial Biofilm Protocols for Enhanced Bacterial Metabolism Research
Published on: July 12, 2024
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
Related Concept Videos
Selected Data About Geographic Locations
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Resistivity
Resistance
Atomic Mass
